For the quarter ended March 2025, Encompass Health (EHC) reported revenue of $1.46 billion, up 10.6% over the same period last year. EPS came in at $1.37, compared to $1.12 in the year-ago quarter.
The reported revenue represents a surprise of +1.31% over the Zacks Consensus Estimate of $1.44 billion. With the consensus EPS estimate being $1.19, the EPS surprise was +15.13%.
While investors closely watch year-over-year changes in headline numbers -- revenue and earnings -- and how they compare to Wall Street expectations to determine their next course of action, some key metrics always provide a better insight into a company's underlying performance.
As these metrics influence top- and bottom-line performance, comparing them to the year-ago numbers and what analysts estimated helps investors project a stock's price performance more accurately.
Here is how Encompass Health performed in the just reported quarter in terms of the metrics most widely monitored and projected by Wall Street analysts:
- Net patient revenue per discharge: $21,816 versus the two-analyst average estimate of $21,472.01.
- Discharges: 64,985 compared to the 65,241 average estimate based on two analysts.
- Net Operating Revenues- Inpatient: $1.42 billion compared to the $1.40 billion average estimate based on two analysts. The reported number represents a change of +10.5% year over year.
- Net Operating Revenues- Outpatient and other: $37.70 million versus the two-analyst average estimate of $37.63 million. The reported number represents a year-over-year change of +13.2%.
View all Key Company Metrics for Encompass Health here>>>
Shares of Encompass Health have returned +0.4% over the past month versus the Zacks S&P 500 composite's -5.1% change. The stock currently has a Zacks Rank #2 (Buy), indicating that it could outperform the broader market in the near term.
Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report
Encompass Health Corporation (EHC): Free Stock Analysis ReportThis article originally published on Zacks Investment Research (zacks.com).
Zacks Investment Research
